Literature DB >> 22081706

Tempol modulates changes in xenobiotic permeability and occludin oligomeric assemblies at the blood-brain barrier during inflammatory pain.

Jeffrey J Lochhead1, Gwen McCaffrey, Lucy Sanchez-Covarrubias, Jessica D Finch, Kristin M Demarco, Colleen E Quigley, Thomas P Davis, Patrick T Ronaldson.   

Abstract

Our laboratory has shown that λ-carrageenan-induced peripheral inflammatory pain (CIP) can alter tight junction (TJ) protein expression and/or assembly leading to changes in blood-brain barrier xenobiotic permeability. However, the role of reactive oxygen species (ROS) and subsequent oxidative stress during CIP is unknown. ROS (i.e., superoxide) are known to cause cellular damage in response to pain/inflammation. Therefore, we examined oxidative stress-associated effects at the blood-brain barrier (BBB) in CIP rats. During CIP, increased staining of nitrosylated proteins was detected in hind paw tissue and enhanced presence of protein adducts containing 3-nitrotyrosine occurred at two molecular weights (i.e., 85 and 44 kDa) in brain microvessels. Tempol, a pharmacological ROS scavenger, attenuated formation of 3-nitrotyrosine-containing proteins in both the hind paw and in brain microvessels when administered 10 min before footpad injection of λ-carrageenan. Similarly, CIP increased 4-hydroxynoneal staining in brain microvessels and this effect was reduced by tempol. Brain permeability to [(14)C]sucrose and [(3)H]codeine was increased, and oligomeric assemblies of occludin, a critical TJ protein, were altered after 3 h CIP. Tempol attenuated both [(14)C]sucrose and [(3)H]codeine brain uptake as well as protected occludin oligomers from disruption in CIP animals, suggesting that ROS production/oxidative stress is involved in modulating BBB functional integrity during pain/inflammation. Interestingly, tempol administration reduced codeine analgesia in CIP animals, indicating that oxidative stress during pain/inflammation may affect opioid delivery to the brain and subsequent efficacy. Taken together, our data show for the first time that ROS pharmacological scavenging is a viable approach for maintaining BBB integrity and controlling central nervous system drug delivery during acute inflammatory pain.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22081706      PMCID: PMC3353792          DOI: 10.1152/ajpheart.00889.2011

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  41 in total

1.  Quantification of early blood-brain barrier disruption by in situ brain perfusion technique.

Authors:  A K Bhattacharjee; T Nagashima; T Kondoh; N Tamaki
Journal:  Brain Res Brain Res Protoc       Date:  2001-10

2.  Blood-brain barrier equilibration of codeine in rats studied with microdialysis.

Authors:  R Xie; M Hammarlund-Udenaes
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

3.  Western blot analysis for nitrotyrosine protein adducts in livers of saline-treated and acetaminophen-treated mice.

Authors:  J A Hinson; S L Michael; S G Ault; N R Pumford
Journal:  Toxicol Sci       Date:  2000-02       Impact factor: 4.849

4.  Blood-brain barrier tight junctions are altered during a 72-h exposure to lambda-carrageenan-induced inflammatory pain.

Authors:  J D Huber; V S Hau; L Borg; C R Campos; R D Egleton; T P Davis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-06-13       Impact factor: 4.733

5.  Superoxide reduction of a disulfide: a model of intracellular redox modulation?

Authors:  D A Peterson; S L Archer; E K Weir
Journal:  Biochem Biophys Res Commun       Date:  1994-05-16       Impact factor: 3.575

6.  Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4).

Authors:  Mark R Hutchinson; Yingning Zhang; Kimberley Brown; Benjamen D Coats; Mitesh Shridhar; Paige W Sholar; Sonica J Patel; Nicole Y Crysdale; Jacqueline A Harrison; Steven F Maier; Kenner C Rice; Linda R Watkins
Journal:  Eur J Neurosci       Date:  2008-07       Impact factor: 3.386

7.  Effect of lambda-carrageenan-induced inflammatory pain on brain uptake of codeine and antinociception.

Authors:  Vincent S Hau; Jason D Huber; Christopher R Campos; Ryan T Davis; Thomas P Davis
Journal:  Brain Res       Date:  2004-08-27       Impact factor: 3.252

8.  Nitric oxide mediates hypoxia-induced changes in paracellular permeability of cerebral microvasculature.

Authors:  Karen S Mark; Amanda R Burroughs; Rachel C Brown; Jason D Huber; Thomas P Davis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-09-04       Impact factor: 4.733

9.  A newly identified role for superoxide in inflammatory pain.

Authors:  Zhi-Qiang Wang; Frank Porreca; Salvatore Cuzzocrea; Karen Galen; Richard Lightfoot; Emanuela Masini; Carolina Muscoli; Vincenzo Mollace; Michael Ndengele; Harry Ischiropoulos; Daniela Salvemini
Journal:  J Pharmacol Exp Ther       Date:  2004-02-26       Impact factor: 4.030

10.  Occludin is a functional component of the tight junction.

Authors:  K M McCarthy; I B Skare; M C Stankewich; M Furuse; S Tsukita; R A Rogers; R D Lynch; E E Schneeberger
Journal:  J Cell Sci       Date:  1996-09       Impact factor: 5.285

View more
  27 in total

1.  Effects of hepatic ischemia-reperfusion injury on the blood-brain barrier permeability to [14C] and [13C]sucrose.

Authors:  Mohammad K Miah; Ulrich Bickel; Reza Mehvar
Journal:  Metab Brain Dis       Date:  2017-08-04       Impact factor: 3.584

Review 2.  Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 3.  Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?

Authors:  Lucy Sanchez-Covarrubias; Lauren M Slosky; Brandon J Thompson; Thomas P Davis; Patrick T Ronaldson
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 4.  Peptides at the blood brain barrier: Knowing me knowing you.

Authors:  Thomas P Davis; Thomas J Abbruscato; Richard D Egleton
Journal:  Peptides       Date:  2015-04-30       Impact factor: 3.750

Review 5.  Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection.

Authors:  Wazir Abdullahi; Dinesh Tripathi; Patrick T Ronaldson
Journal:  Am J Physiol Cell Physiol       Date:  2018-06-27       Impact factor: 4.249

6.  Effects of Muscone on the Expression of P-gp, MMP-9 on Blood-Brain Barrier Model In Vitro.

Authors:  Guang-Yun Wang; Ning Wang; Hua-Ning Liao
Journal:  Cell Mol Neurobiol       Date:  2015-05-15       Impact factor: 5.046

Review 7.  P-glycoprotein trafficking as a therapeutic target to optimize CNS drug delivery.

Authors:  Thomas P Davis; Lucy Sanchez-Covarubias; Margaret E Tome
Journal:  Adv Pharmacol       Date:  2014-08-23

8.  Regulation of blood-brain barrier integrity by microglia in health and disease: A therapeutic opportunity.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  J Cereb Blood Flow Metab       Date:  2020-09-14       Impact factor: 6.200

Review 9.  The effects of hypertension on the cerebral circulation.

Authors:  Paulo W Pires; Carla M Dams Ramos; Nusrat Matin; Anne M Dorrance
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-12       Impact factor: 4.733

Review 10.  Targeted drug delivery to treat pain and cerebral hypoxia.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Pharmacol Rev       Date:  2013-01-23       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.